Supernus Pharmaceuticals (SUPN) FCF Margin Growth (3y) (2014 - 2025)
Supernus Pharmaceuticals (SUPN) FCF Margin Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 253.00 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -1,444.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -1,941.00 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 4,671.00 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1,067.00 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -42,016.00 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 830.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 895.00 |
| 10 | Supernus Pharmaceuticals | 2.57 Bn | 2.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -739.00 |
| Sep 30, 2025 | -3,980.00 |
| Jun 30, 2025 | -688.00 |
| Mar 31, 2025 | 1,774.00 |
| Dec 31, 2024 | -528.00 |
| Sep 30, 2024 | 3,312.00 |
| Jun 30, 2024 | -1,162.00 |
| Mar 31, 2024 | -109.00 |
| Dec 31, 2023 | 529.00 |
| Sep 30, 2023 | 1,971.00 |
| Jun 30, 2023 | -8,617.00 |
| Mar 31, 2023 | 2,505.00 |
| Dec 31, 2022 | -2,500.00 |
| Sep 30, 2022 | -2,878.00 |
| Jun 30, 2022 | 1,461.00 |
| Mar 31, 2022 | -3,588.00 |
| Dec 31, 2021 | 241.00 |
| Sep 30, 2021 | -6,321.00 |
| Jun 30, 2021 | 2,646.00 |
| Mar 31, 2021 | -208.00 |